Applied Genetic Technologies Corporation (AGTC) financial statements (2023 and earlier)

Company profile

Business Address 14193 NW 119TH TERRACE
ALACHUA, FL 32615
State of Incorp. DE
Fiscal Year End June 30
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:72,771107,10080,50082,000104,905126,70098,532
Cash and cash equivalents72,771105,05238,46326,70331,06530,70628,868
Short-term investments 2,00041,99555,29273,84095,99469,664
Other undisclosed cash, cash equivalents, and short-term investments 48425   
Receivables   13210174954
Other undisclosed current assets2,5972,6072,4642,2714,0093,3613,089
Total current assets:75,368109,70782,96484,284109,124130,235102,575
Noncurrent Assets
Finance lease, right-of-use asset113480
Operating lease, right-of-use asset3,1673,1673,422
Property, plant and equipment4,4164,6584,3114,4305,2542,6612,627
Long-term investments and receivables7,9378,0008,096 1,98011,74974,183
Long-term investments7,9378,0008,096 1,98011,74974,183
Intangible assets, net (including goodwill)1,3451,2871,0981,0139681,2191,321
Intangible assets, net (excluding goodwill)1,3451,2871,0981,0139681,2191,321
Other noncurrent assets1261133485441,2065991
Other undisclosed noncurrent assets   1,945 2,000 
Total noncurrent assets:17,00217,25917,3557,9329,40817,68878,222
TOTAL ASSETS:92,370126,966100,31992,216118,532147,923180,797
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,6744,7694,6533,7373,1314,2922,922
Accounts payable1,6741,8791,3551,3319459981,331
Employee-related liabilities 2,8903,2982,4062,1861,7801,591
Taxes payable     1,514 
Debt6,7272,21948    
Deferred revenue and credits6,29520,996 
Other undisclosed current liabilities15,71312,7268,2625,6184,9692,86851,821
Total current liabilities:24,11419,71412,9639,35514,39528,15654,743
Noncurrent Liabilities
Long-term debt and lease obligation3,1333,4184,108    
Finance lease, liability  38
Operating lease, liability3,1333,4184,070
Liabilities, other than long-term debt952992,5554,1524,9554,43816,766
Deferred revenue and credits6104,43816,766
Other liabilities952992,5554,1524,345  
Other undisclosed noncurrent liabilities13,53817,7279,677    
Total noncurrent liabilities:16,76621,44416,3404,1524,9554,43816,766
Total liabilities:40,88041,15829,30313,50719,35032,59471,509
Stockholders' equity
Stockholders' equity attributable to parent51,49085,80871,01678,70999,182115,329109,288
Common stock43432518181818
Treasury stock, value(256)(211)(88)(85)(49)  
Additional paid in capital327,235325,245252,519214,324210,139204,937199,303
Accumulated deficit(275,532)(239,269)(181,440)(135,548)(110,926)(89,626)(90,033)
Total stockholders' equity:51,49085,80871,01678,70999,182115,329109,288
TOTAL LIABILITIES AND EQUITY:92,370126,966100,31992,216118,532147,923180,797

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Revenues5005002,45341,69224,18639,47347,361
Gross profit: 5002,45341,69224,18639,47347,361
Operating expenses(63,642)(58,951)(49,395)(46,042)(46,570)(37,571)(49,450)
Other undisclosed operating income500      
Operating income (loss):(63,142)(58,451)(46,942)(4,350)(22,384)1,902(2,089)
Nonoperating income (expense)(2,148)(1,390)1,1802,4551,176905708
Investment income, nonoperating351161,1852,0091,301952711
Other nonoperating income (expense)  (5)446(125)(47)(3)
Interest and debt expense(2,183)(1,506)(8)    
Other undisclosed income from continuing operations before equity method investments, income taxes2,1831,5068    
Income (loss) from continuing operations before equity method investments, income taxes:(65,290)(59,841)(45,762)(1,895)(21,208)2,807(1,381)
Loss from equity method investments(109)(96)(47)(35)   
Income (loss) from continuing operations before income taxes:(65,399)(59,937)(45,809)(1,930)(21,208)2,807(1,381)
Income tax expense (benefit)2,1492,108(83)(76)(72)(2,400) 
Income (loss) before gain (loss) on sale of properties:(63,250)(57,829)(45,892)(2,006)(21,280)407(1,381)
Other undisclosed net loss    (20)  
Net income (loss) available to common stockholders, diluted:(63,250)(57,829)(45,892)(2,006)(21,300)407(1,381)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net income (loss):(63,250)(57,829)(45,892)(2,006)(21,300)407(1,381)
Comprehensive income (loss), net of tax, attributable to parent:(63,250)(57,829)(45,892)(2,006)(21,300)407(1,381)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: